Psychiatric medications, science, marketing, psychiatry in general, and occasionally clinical psychology. Questioning the role of key opinion leaders and the use of "science" to promote commercial ends rather than the needs of people with mental health concerns.
Visit Clinical Psychology
The Cymbalta Schatz-Storm: Duplicate Publication and Lying by Omission
Posted on September 25, 2008
This post details the duplicate publication of data on the antidepressant duloxetine (Cymbalta). Marketing and science collide to product hideous offspring: an experimercial that pimps Lilly's bogus Depression Hurts marketing for Cymbalta using the exact same (weak) data twice. Data were published in the Journal of Clinical Psychiatry (JCP), and then the same data were published a second time in the Journal of Psychiatric Research (JPR), a blatant violation of JPR policy. Oh, and Alan Schatzberg, president-elect for the American Psychiatric Association is involved in the story.The study...
Original article link
Subscribe to Clinical Psychology